The NQO1 mRNA expression levels were significantly associated with the pathological stages in pancreatic adenocarcinoma, thyroid carcinoma, pan-kidney cohort, invasive breast carcinoma, and kidney chromophobe. This evidence concerns the gene NQO1 and pancreatic adenocarcinoma.